ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.16
0.05%
US Tech 100
20,192.00
-0.15%
S&P 500
5,845.48
0.16%
US Dollar vs CAD
1.43655
0.01%
Bitcoin
96,743.67
2.37%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) News

PRTC

PureTech Health (PRTC)

PureTech Health PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateTimeSourceHeadlineSymbolCompany
01/09/20256:00AMBusiness WirePureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)NASDAQ:PRTCPureTech Health PLC
01/08/20256:00AMBusiness WirePureTech to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
01/06/20251:00AMBusiness WirePureTech Appoints UBS as UK Corporate BrokerNASDAQ:PRTCPureTech Health PLC
12/16/20241:00AMBusiness WirePureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b TrialNASDAQ:PRTCPureTech Health PLC
12/11/20246:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024NASDAQ:PRTCPureTech Health PLC
12/09/20241:00AMBusiness WirePureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual MeetingNASDAQ:PRTCPureTech Health PLC
11/20/20246:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
11/05/20246:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial OfficerNASDAQ:PRTCPureTech Health PLC
10/30/20246:00AMBusiness WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
10/21/20241:00AMBusiness WirePureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing RoundNASDAQ:PRTCPureTech Health PLC
10/09/20241:00AMBusiness WirePureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual MeetingNASDAQ:PRTCPureTech Health PLC
10/01/20246:00AMBusiness WirePureTech to Present at CHEST 2024 Annual MeetingNASDAQ:PRTCPureTech Health PLC
09/27/20241:00AMBusiness WirePureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in AdultsNASDAQ:PRTCPureTech Health PLC
09/06/20241:00AMBusiness WirePureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted TherapiesNASDAQ:PRTCPureTech Health PLC
08/28/20243:31PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
08/28/20246:29AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
08/28/20241:01AMBusiness WirePureTech Health plc – Half-Year ReportNASDAQ:PRTCPureTech Health PLC
08/22/20243:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
08/22/20241:00AMBusiness WirePureTech Appoints Michele Holcomb, PhD, to Board of DirectorsNASDAQ:PRTCPureTech Health PLC
08/21/20241:00AMBusiness WirePureTech Health: Notice of Half-Yearly ResultsNASDAQ:PRTCPureTech Health PLC
08/13/20246:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
07/23/20247:26AMBusiness WirePureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of CommercialNASDAQ:PRTCPureTech Health PLC
06/24/202411:00AMBusiness WirePureTech Health: Completion of Tender Offer & Total Voting RightsNASDAQ:PRTCPureTech Health PLC
06/24/20241:00AMBusiness WirePureTech Health: Results of the Tender OfferNASDAQ:PRTCPureTech Health PLC
06/20/20241:00AMBusiness WirePureTech Announces Change of Board RoleNASDAQ:PRTCPureTech Health PLC
06/18/20246:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management TeamNASDAQ:PRTCPureTech Health PLC
06/13/20243:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
06/13/202412:15PMBusiness WirePureTech Health: Results of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
06/06/20243:39PMEdgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
06/06/20243:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Your Recent History

USOTC
WAOLF
Wide Open Agriculture (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads